Cargando…
Circulating NOS3 Modulates Left Ventricular Remodeling following Reperfused Myocardial Infarction
PURPOSE: Nitric oxide (NO) is constitutively produced and released from the endothelium and several blood cell types by the isoform 3 of the NO synthase (NOS3). We have shown that NO protects against myocardial ischemia/reperfusion (I/R) injury and that depletion of circulating NOS3 increases within...
Autores principales: | Gorressen, Simone, Stern, Manuel, van de Sandt, Annette M., Cortese-Krott, Miriam M., Ohlig, Jan, Rassaf, Tienush, Gödecke, Axel, Fischer, Jens W., Heusch, Gerd, Merx, Marc W., Kelm, Malte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397096/ https://www.ncbi.nlm.nih.gov/pubmed/25875863 http://dx.doi.org/10.1371/journal.pone.0120961 |
Ejemplares similares
-
Depletion of circulating blood NOS3 increases severity of myocardial infarction and left ventricular dysfunction
por: Merx, Marc W., et al.
Publicado: (2013) -
Endothelial NOS (NOS3) impairs myocardial function in developing sepsis
por: van de Sandt, Annette M., et al.
Publicado: (2013) -
Neuronal NOS-inhibition in the setting of septic cardiomyopathy
por: Sandt, A van de, et al.
Publicado: (2010) -
Pharmacological CCR1 blockade limits infarct size and preserves cardiac function in a chronic model of myocardial ischemia/reperfusion
por: Van de Sandt, A, et al.
Publicado: (2011) -
Endothelial nitric oxide synthase deficiency and inducible nitric oxide synthase inhibition in the setting of septic cardiomyopathy
por: Sandt, A Van de, et al.
Publicado: (2009)